Repressed experiments for module 206

Experiment nameClinical attributes
Alizadeh00_CLL_44_Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Chronic lymphocytic leukemia (B lymphoma), Leukemia (B lymphoma), Leukemia or leukemia cell line (B lymphoma)
Alizadeh00_DLCL_0008Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma), GC B like DLBCL (B lymphoma)
Bhattacharjee01_AD-330t2-A279-10Stage T2 (Lung cancer), Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Adenocarcinoma (Lung cancer), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*)
Blader01_HFF_infected_with_PDS_tacyzoites_24_hourFibroblasts (Fibroblast infection*), Skin fibroblasts (Fibroblast infection*), Toxoplasma infected skin fibroblasts (Fibroblast infection*)
Boldrick02_Diversity_Dataset_Untreated_timecourse_2_0_hrLymphocytes (Stimulated PBMC*), Monocytes (Stimulated PBMC*), Primary blood mononuclear cells (Stimulated PBMC*), Hematologic samples (Stimulated PBMC*), Hematologic samples and cell lines (Stimulated PBMC*), Unstimulated immune cells (Stimulated PBMC)
Chen02_HCC_HK41Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), p53 positive hepatocellular carcinoma (Liver cancer)
Chen02_HCC_HK46Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), p53 positive hepatocellular carcinoma (Liver cancer)
Garber01_166_96_SCCCancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*)
Nutt03_Brain_NO_8Cancer (Gliomas*), CNS tumor (Gliomas*), Cancer and cell line (Gliomas*), CNS tissue, cancer or cell line (Gliomas*), CNS cancer or cell line (Gliomas*), Alive prognosis (Gliomas), Non-classic anaplastic oligodendroglioma (Gliomas)
Perou00_BC123A_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Perou00_BC124B_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Perou00_BC214A_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Perou00_BC2_LN2Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Perou00_BC708A_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Perou00_HMEC_CBreast cancer cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Human mammary epithelial cells - HMECs (Breast cancer), Human mammary epithelial cells (HMECs) or normal breast tissue (Breast cancer)
Perou00_Hs578T_NCIBreast cancer cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Mesenchemal cell line (Breast cancer)
Perou00_MOLT4Cell line (Breast cancer), Cancer and cell line (Breast cancer*)
Perou00_SK_BR_3Breast cancer cell line (Breast cancer), Epithelial cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*)
Perou00_SW872Cell line (Breast cancer), Cancer and cell line (Breast cancer*), Mesenchemal cell line (Breast cancer)
Pomeroy02_Brain_PNET_3Cancer (Neuro tumors*), CNS tumor (Neuro tumors*), Cancer and cell line (Neuro tumors*), CNS tissue, cancer or cell line (Neuro tumors*), CNS cancer or cell line (Neuro tumors*)
Ramaswamy01_Tumor__Lymphoma_Follicular_FSCC_S93_23356Cancer (Various tumors), Cancer and cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*), Hematologic cancer (Various tumors), B cells (Various tumors), Follicular lymphoma (Various tumors), Lymphoma (Various tumors), Lymphocytes (Various tumors), Primary blood mononuclear cells (Various tumors), Monocytes (Various tumors), Hematologic samples (Various tumors), Hematologic samples and cell lines (Various tumors), Hematologic cancer and cell line (Various tumors)
Ramaswamy01_Tumor__Lymphoma_Follicular_FSCC_S98_10416Cancer (Various tumors), Cancer and cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*), Hematologic cancer (Various tumors), B cells (Various tumors), Follicular lymphoma (Various tumors), Lymphoma (Various tumors), Lymphocytes (Various tumors), Primary blood mononuclear cells (Various tumors), Monocytes (Various tumors), Hematologic samples (Various tumors), Hematologic samples and cell lines (Various tumors), Hematologic cancer and cell line (Various tumors)
Ramaswamy01_Tumor__Lymphoma_Follicular_FSCC_S98_5894Cancer (Various tumors), Cancer and cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*), Hematologic cancer (Various tumors), B cells (Various tumors), Follicular lymphoma (Various tumors), Lymphoma (Various tumors), Lymphocytes (Various tumors), Primary blood mononuclear cells (Various tumors), Monocytes (Various tumors), Hematologic samples (Various tumors), Hematologic samples and cell lines (Various tumors), Hematologic cancer and cell line (Various tumors)
Ramaswamy01_Tumor__Lymphoma_Large_B-Cell_L_B_CELL_S98_1217_RCancer (Various tumors), Cancer and cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*), Hematologic cancer (Various tumors), B cells (Various tumors), Lymphoma (Various tumors), Lymphocytes (Various tumors), Primary blood mononuclear cells (Various tumors), Monocytes (Various tumors), Hematologic samples (Various tumors), Hematologic samples and cell lines (Various tumors), Hematologic cancer and cell line (Various tumors), Diffuse large B cell lymphoma - DLBCL (Various tumors), Diffuse large B cell lymphoma tumor or cell line (Various tumors)
Ross01_BJ_hTERT_PD210_Fibroblasts_UTSWCell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60)
Sorlie01_BC111A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC111B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC114A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer)
Sorlie01_BC115B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC116A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer)
Sorlie01_BC123B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC124A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Grade 1 (Breast cancer)
Sorlie01_BC1257Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Wild type p53 tumor (Breast cancer)
Sorlie01_BC14Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Mutated p53 tumor (Breast cancer)
Sorlie01_BC16Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC17Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer)
Sorlie01_BC2Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC206A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC23Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Grade 3 (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC305A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC308B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer)
Sorlie01_BC402B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 3 (Breast cancer)
Sorlie01_BC406A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer)
Sorlie01_BC704B_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 1 (Breast cancer)
Sorlie01_BC708B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC710A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 3 (Breast cancer)
Sorlie01_BC790Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC805A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Grade 3 (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC807A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 3 (Breast cancer)
Sorlie01_Normal_Breast1Breast tissue, cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Human mammary epithelial cells (HMECs) or normal breast tissue (Breast cancer), Normal breast tissue (Breast cancer), Normal female hormonal tissue (Breast cancer), Normal female hormonal tissue and cells (Breast cancer), Normal tissue (Breast cancer)
Sorlie01_Normal_Breast2Breast tissue, cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Human mammary epithelial cells (HMECs) or normal breast tissue (Breast cancer), Normal breast tissue (Breast cancer), Normal female hormonal tissue (Breast cancer), Normal female hormonal tissue and cells (Breast cancer), Normal tissue (Breast cancer)
Whitfield02_2h_mitotic_selectionCell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*), M phase (HeLa cell cycle)